FDMT 4D Molecular Therapeutics, Inc. logo

FDMT 4D Molecular Therapeutics, Inc.

Healthcare
$8.60-1.04%ClosedMarket Cap: $449.6M

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

155

13F Shares

53,424,323

Ownership %

95.2%

New Positions

30

Increased Positions

87

Closed Positions

13

Reduced Positions

37

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
SURISimplify Propel Opportunities ETF70,4300.90%
BBCVirtus Biotech Clinical Trials ETF25,1540.65%
XBI1,318,0680.16%
LABUDirexion Daily S&P Biotech Bull 3X ETF67,1760.14%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF310,9500.12%
IWCiShares Micro-Cap ETF111,2910.08%
IJE111,2910.08%
VFMO116,2960.07%
AVSCAvantis U.S. Small Cap Equity ETF86,6250.04%
IBBiShares Biotechnology ETF338,7440.04%
PRFZInvesco RAFI US 1500 Small-Mid ETF94,4500.03%
NAJ378,2300.03%
IWNiShares Russell 2000 Value ETF378,2300.03%
VSTCX92,8300.03%
VTWV29,2540.03%
PKWInvesco BuyBack Achievers ETF41,4280.02%
VTWO199,2640.01%
DFASDimensional - US Small Cap ETF152,1270.01%
NJM1,070,3000.01%
IWMiShares Russell 2000 ETF1,070,3000.01%